drugset / Trial / NCT00837837

Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents

NCT00837837

Phase 1 Completed 36 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the pharmacokinetic parameters of chlorpheniramine in children and adolescents.

Timeline

Start
2008-12-21
Primary completion
2009-02-02
Completion
2009-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorpheniramine Unknown 1 mg Oral
Subject Chlorpheniramine Unknown 4 mg Oral

Indications